Creative Medical Technology Holdings, Inc. announced the successful completion of patient enrollment in its FDA-cleared ADAPT clinical trial evaluating CELZ-201 , the Company's proprietary perinatal...
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared Adapt Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
